Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Bleomycin (sulfate) | 9041-93-4 | 99.9% | 1523 | 1 G
SDP

Catalog No. 5000386837
Encompass_Preferred

Bleomycin sulfate is a DNA synthesis inhibitor, a DNA damaging agent, and an antitumor antibiotic. It causes DNA lesions such as single and double-strand breaks and apurinic/apyrimidinic sites. It is considered a radiomimetic compound due to its genetic effects similar to ionizing radiation. It can be used to induce pulmonary fibrosis models.

  • DNA synthesis inhibitor
  • DNA damaging agent
  • Antitumor antibiotic
  • Induces DNA lesions like single and double-strand breaks
  • Radiomimetic compound
  • Used to induce pulmonary fibrosis models
  • High bioavailability
  • High plasma elimination and urinary excretion rates

Catalog No. 50-003-86837 Supplier Medchemexpress LLC Supplier No. HY175651G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Bleomycin sulfate is a DNA synthesis inhibitor, a DNA damaging agent, and an antitumor antibiotic. It causes DNA lesions such as single and double-strand breaks and apurinic/apyrimidinic sites. It is considered a radiomimetic compound due to its genetic effects similar to ionizing radiation. It can be used to induce pulmonary fibrosis models.

  • DNA synthesis inhibitor
  • DNA damaging agent
  • Antitumor antibiotic
  • Induces DNA lesions like single and double-strand breaks
  • Radiomimetic compound
  • Used to induce pulmonary fibrosis models
  • High bioavailability
  • High plasma elimination and urinary excretion rates

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.